← Leaderboards
P. Renee Yew
University Of Texas Hlth Sci Ctr San Ant
$1,231,324
Attributed
$1,231,324
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $245K · FY2006–08$250K$187.5K$125K$62.5K$0
'06
'07
'08
Funding mix
By agency
NIH$1,231,324 · 1
By mechanism
R01$1,231,324 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Alan E Tomkinson$18,223,498
- Patrick Sung$43,318,700
- Sang Eun Lee$7,736,394
Others in their field
Top investigators on “Dna Damage”
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- F Peter Guengerich · Vanderbilt University$33,973,148
- Aziz Sancar · University Of North Carolina Chapel Hill$31,216,731
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
- John A Tainer · Scripps Research Institute$27,554,249
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$27,391,656
Research focus
Dna DamageProliferating Cell Nuclear AntigenProteolysisDna RepairCell CyclePhosphorylationIonizing RadiationCdk2 GeneCancer CellBinding (Molecular Function)Cell Cycle ProteinsCell DivisionCell Growth RegulationCell NucleusCell Cycle ProgressionCell Cycle CheckpointBiological ModelsChromatinCyclin Dependent KinaseCyclin-Dependent Kinase InhibitorCyclin-Dependent KinasesCyclinsDna BiosynthesisCholine Kinase
Grant awards (5)
Cyclin-dependent kinase inhibitor regulation during the Xenopus cell cycle$242,260
R01 · FY2008 · GM · contact PI
Cyclin-dependent kinase inhibitor regulation during the Xenopus cell cycle$242,260
R01 · FY2007 · GM · contact PI
CDK inhibitor regulation during the Xenopus cell cycle$245,004
R01 · FY2006 · GM · contact PI
CDK inhibitor regulation during the Xenopus cell cycle$250,900
R01 · FY2004 · GM
CDK inhibitor regulation during the Xenopus cell cycle$250,900
R01 · FY2003 · GM